All posts in Neuro

OrthoNeuro Technologies Announces an Exclusive Partnership with Southern California University of Health Sciences

OrthoNeuro Technologies, Inc. (http://www.ortho-neuro.com), a technology company that designs and integrates products and services focused on technique skills development to increase proficiency in the Spinal Care Professional community, announces an exclusive partnership to provide the Dynadjust Spinal Manipulation Training System …

Continue Reading...

InVivo Therapeutics Co-Founder Dr. Robert S. Langer Awarded Annual Innovation Award from The Economist

CAMBRIDGE, Mass., Dec 12, 2011 (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (otc/bb:NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal

Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain

LAS VEGAS, Dec 08, 2011 (BUSINESS WIRE) -- Spinal Modulation, a privately held global medical device company, announced today that the Spinal Modulation Neurostimulator System has received

Paralyzed man stands, steps after spine treatment

NEW YORK (Reuters) – A man left paralyzed after a car accident was able to stand and take steps after electrical stimulation of his spinal cord in what

NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology

NEW YORK, Dec. 9, 2010 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with product and service revenues, global research and

InVivo exceeds private placement by $2.5M

InVivo Therapeutics today said that its previously announced $10.5 million private placement actually brought in $13 milion with additional units being purchased by Spencer Trask Ventures Inc., which

Vycor Medical Announces Acquisition of Therapeutic and Diagnostic Vision Restoration Company — NovaVision

BOHEMIA, NY, Nov 12, 2010 (MARKETWIRE via COMTEX) -- Vycor Medical, Inc. (OTCBB: VYCO | PowerRating) (www.vycormedical.com), a medical device company that designs, develops and markets

InVivo Therapeutics opens Medford facility

InVivo Therapeutics Corp., a life sciences company developing technologies for the treatment of spinal cord injuries, has signed a lease to open its first manufacturing and development facility

Neuralstem Awarded Three Federal Grants

ROCKVILLE, Md., Nov. 2, 2010 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been awarded three Federal grants, totaling $733,438 through the Patient Protection and Affordable Care

Zynex Announces New Chief Financial Officer

LITTLETON, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Anthony Scalese has

Stryker Said to Be in Talks on Boston Scientific Unit

Aug. 17 (Bloomberg) -- Stryker Corp., a maker of artificial hips and knees, is in advanced talks to buy Boston Scientific Corp.’s pain-management device unit for about $1.5

J&J Buying Stroke-Treatment Co Micrus For $480M

Johnson & Johnson (JNJ) said Monday it plans to bolster its lineup of stroke-prevention products by buying Micrus Endovascular Corp. (MEND) for about $480 million, marking the latest

Medtronic Launches Award-Winning Neuro Oncology Surgical Imaging System in the United States

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in

Axerion gets $750,000 for neuro research

Connecticut Innovations today said it has invested $750,000 in New Haven-based Axerion Therapeutics Inc., a Yale University spinoff that is developing treatments for neurological injuries and diseases. Axerion was

Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA(TM) (dalfampridine)

HAWTHORNE, N.Y., Mar 22, 2010 (BUSINESS WIRE) -- Acorda Therapeutics, Inc. (ACOR 34.95, +0.11, +0.32%)today announced that the Company has submitted applications to extend patent protection for